Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suma Babu

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Annals of Neurology|May 10, 2018
Integrated magnetic resonance imaging and [<sup>11</sup> C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosisMohamad J Alshikho, Nicole R Zürcher, Marco L Loggia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET RadioligandsDonatienne Van Weehaeghe, Suma Babu, Joke De Vocht, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Neuroimage. Clinical|November 22, 2017
Imaging of glia activation in people with primary lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Nicole R Zürcher, et al.
Muscle & Nerve|February 28, 2025
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral SclerosisAlexandra Lovett, Sowmya Chary, Suma Babu, et al.
Muscle & Nerve|June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidenceAmanda M Dios, Suma Babu, Eric J Granucci, et al.
Brain : a Journal of Neurology|April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trialSuma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
Neuroimage. Clinical|September 22, 2022
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosisRobert L Barry, Angel Torrado-Carvajal, John E Kirsch, et al.
Brain : a Journal of Neurology|January 30, 2024
Characterization of cortico-meningeal translocator protein expression in multiple sclerosisElena Herranz, Constantina A Treaba, Valeria T Barletta, et al.
Muscle & Nerve|September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosisJames D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Annals of Neurology|May 10, 2018
Integrated magnetic resonance imaging and [<sup>11</sup> C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosisMohamad J Alshikho, Nicole R Zürcher, Marco L Loggia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET RadioligandsDonatienne Van Weehaeghe, Suma Babu, Joke De Vocht, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Neuroimage. Clinical|November 22, 2017
Imaging of glia activation in people with primary lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Nicole R Zürcher, et al.
Muscle & Nerve|February 28, 2025
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral SclerosisAlexandra Lovett, Sowmya Chary, Suma Babu, et al.
Muscle & Nerve|June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidenceAmanda M Dios, Suma Babu, Eric J Granucci, et al.
Brain : a Journal of Neurology|April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trialSuma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
Neuroimage. Clinical|September 22, 2022
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosisRobert L Barry, Angel Torrado-Carvajal, John E Kirsch, et al.
Brain : a Journal of Neurology|January 30, 2024
Characterization of cortico-meningeal translocator protein expression in multiple sclerosisElena Herranz, Constantina A Treaba, Valeria T Barletta, et al.
Muscle & Nerve|September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosisJames D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Pageof 6